Physician profile
Brett E Ekstrom
NPI 1104335900
$1,082.81
in general payments reported to CMS, 2019-2025
17 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.89 · 2023: $257 · 2024: $363 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $239.48 | 2023-2025 | Ffrct |
| E.R. Squibb & Sons, L.L.C. | $148.16 | 2024-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $137.95 | 2021-2025 | |
| Amgen INC. | $84.19 | 2024-2025 | Repatha |
| Pfizer INC. | $60.43 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $53.65 | 2024-2025 | Onpattro |
| Glaxosmithkline, LLC. | $51.09 | 2023-2024 | Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $50.29 | 2021-2025 | Airsupra |
| Janssen Pharmaceuticals, INC | $47.83 | 2023-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $36.53 | 2025 | Gardasil 9, Capvaxive, M-M-R II |
| Bayer Healthcare Pharmaceuticals INC. | $34.07 | 2025 | |
| Lilly USA, LLC | $32.17 | 2024-2025 | Jardiance, Mounjaro |
| Abbott Laboratories | $24.72 | 2024 | Freestyle Libre 3 |
| Philips North America LLC | $23.08 | 2024 | (Ck7) Extended Holter |
| Vital Connect, INC | $20.89 | 2025 | Vitalpatch Rtm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.86 | 2025 | Wegovy |
| Ardelyx, INC. | $18.42 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Ekstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.